This OMB action
is not an approval to conduct or sponsor an information collection
under the Paperwork Reduction Act of 1995. This action has no
effect on any current approvals. If OMB has assigned this ICR a new
OMB Control Number, the OMB Control Number will not appear in the
active inventory. For future submissions of this information
collection, reference the OMB Control Number provided. In
accordance with 5 CFR 1320, OMB is withholding approval for this
request at this time. Prior to the publication of the final rule,
the agency should provide a summary of all comments related to the
information collection and anychanges made in response to these
comments.
Inventory as of this Action
Requested
Previously Approved
36 Months From Approved
0
0
0
0
0
0
0
0
0
EPA is proposing to add hazardous
pharmaceutical wastes to the existing Universal Waste Rule (UWR) at
40 CFR Part 273. This proposed rule would facilitate better
management of pharmaceutical wastes by streamlining the generator
requirements and encouraging generators of hazardous pharmaceutical
wastes to manage them under the provisions of the UWR, which
ensures that these hazardous pharmaceutical wastes are properly
disposed of and treated as hazardous wastes. In addition, this
proposed rule would facilitate the implementation of pharmaceutical
take-back programs, and thus would redirect hazardous and
non-hazardous pharmaceutical wastes from municipal solid waste
landfills and sewer systems to hazardous waste landfills and
incinerators.
EPA is proposing to add
hazardous pharmaceutical wastes to the Universal Waste Rule (UWR).
This is expected to improve management of hazardous and
non-hazardous pharmaceutical wastes, as well as decreased
regulatory burden for many hazardous pharmaceutical waste
generators. The increase in burden would result from the need for
universal pharmaceutical waste handlers to read the rule that adds
hazardous pharmaceutical wastes to the existing UWR. In addition,
the large quantity handlers would also be required to maintain
records of all universal pharmaceutical waste shipments. The total
increase in new annual paperwork requirements in the proposed rule
is approximately 960 hours. However, in addition to the new
paperwork requirements for respondents, the proposed rule would
result in annual respondent burden savings under the existing
paperwork requirements (associated with four existing EPA ICRs) of
approximately 1,900 hours. Taking both the new proposed and
existing RCRA requirements into account, the proposed rule would
result in a net reduction in annual paperwork burden of
approximately 935 hours.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.